NRX Pharmaceuticals NRXP
NASDAQ NRXP
$2.85 -0.07 (-2.40%)
At close: Oct 1, 2026 · 4:00 PM EDT

NRX Pharmaceuticals (NRXP) Total Current Liabilities (2017 - 2026)

Updated

NRX Pharmaceuticals (NRXP) reported Total Current Liabilities of $33.87 million for Q2 2026, down 16.3% from $40.45 million a year earlier but up 34.5% from the prior quarter.

Analysis

NRX Pharmaceuticals (NRXP) Total Current Liabilities (2017 - 2026) Analysis & Trends

At the end of FY2025, NRX Pharmaceuticals posted Total Current Liabilities of $28.58 million, up 30.7% from FY2024.

  • Total Current Liabilities has increased for four consecutive years, though with a five-year compound annual growth rate of -9.1% (FY2020 to FY2025).
  • By year, Total Current Liabilities came in at $21.86 million in FY2024 (+14.8%), $19.05 million in FY2023 (+22.2%), $15.59 million in FY2022 (+30.7%) and $11.92 million in FY2021 (-74.2%).
  • Five-year quarterly Total Current Liabilities spans a low of $11.92 million in Q4 2021 and a high of $40.59 million in Q3 2025.
  • Year over year, Total Current Liabilities gained in four of the last six quarters, with growth averaging 18.5%.
  • The high point for year-over-year Total Current Liabilities in five years was Q3 2025 (growth of 100.0%); the low point was Q4 2021 (a decline of 74.2%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $25.18 million (Q1 2026), $28.58 million (Q4 2025) and $40.59 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 54.90 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 41.64 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -31.55 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 11.02 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 3.94 Bn
10 NRX Pharmaceuticals 126.02 Mn 77.61 Mn 426,000.00 33.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 33.87 Mn
Mar 31, 2026 25.18 Mn
Dec 31, 2025 28.58 Mn
Sep 30, 2025 40.59 Mn
Jun 30, 2025 40.45 Mn
Mar 31, 2025 32.75 Mn
Dec 31, 2024 21.86 Mn
Sep 30, 2024 20.30 Mn
Dec 31, 2023 19.05 Mn
Sep 30, 2023 19.33 Mn
Jun 30, 2023 22.62 Mn
Mar 31, 2023 22.06 Mn
Dec 31, 2022 15.59 Mn
Dec 31, 2021 11.92 Mn
Sep 30, 2021 36.77 Mn
Jun 30, 2021 57.80 Mn
Dec 31, 2020 46.16 Mn
Sep 30, 2020 379,198.00
Jun 30, 2020 297,238.00
Mar 31, 2020 316,381.00
API Access

NRX Pharmaceuticals Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=NRXP&period=max&api_key=YOUR_API_KEY